Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Corneal Endothelial Health of Dry Eye Disease Subjects Treated With Cyclosporine Ophthalmic Solution, 0.1%

NCT06329661 is registered in ClinicalTrials.gov with Novaliq GmbH as lead sponsor.

NCT NCT06329661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06329661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Corneal Endothelial Health of Dry Eye Disease Subjects Treated With Cyclosporine Ophthalmic Solution, 0.1%
Lead sponsor
Novaliq GmbH
Phase
Phase 4
Overall status
Completed
Start date
April 22, 2024
Completion date
July 30, 2025
Enrollment
204 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease, endothelial cell